ANN ARBOR, Mich.—Wacker Chemical Corp. has expanded its footprint in the silicone-coated medical space, adding Pennsylvania-based Bio Med Sciences Inc. to its portfolio.
Terms of the transaction, which closed May 30, were not disclosed.
"With our own prototyping ability, we now have an opportunity to demonstrate the performance attributes and advantages of our silicones to coaters, converters and designers of medical devices," said Christoph Kowitz, CEO and president of Wacker Chemical Corp., the U.S. branch of Munich-based Wacker Chemie A.G.
The new business unit, Wacker Silicone Manufactured Innovations L.L.C., will provide contract manufacturing services for the overall advanced wound care and scar management markets.
Wacker will leverage Bio Med's expertise in processing recommendations for burn treatment, dermatology, cosmetic surgery, long-term care and rehabilitation products.
WSMI is based in Allentown, Pa. Existing Bio Med Sciences consumer products and related brands will remain with Bio Med Sciences and are not part of the acquisition.
"We will be able to support coaters who do not use silicones or lack access to assets for coating with silicones," Kowitz said.
A majority of Bio Med's work force will transfer to WSMI, Wacker said.